Kalpataru Multiplier Ltd.

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private

BSE4901.5043.6 (+0.9 %)

PREV CLOSE () 4857.90

OPEN PRICE () 4874.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 139669

TODAY'S LOW / HIGH ()4862.05 4935.00

52 WK LOW / HIGH ()3211.05 5519.1

NSE4910.4042.75 (+0.88 %)

PREV CLOSE() 4867.65

OPEN PRICE () 4868.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 4910.40 (44)

VOLUME 160192

TODAY'S LOW / HIGH() 4858.00 4937.40

52 WK LOW / HIGH ()3186.3 5520

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1973

Management Info :

Basudeo N Singh - Chairman Sandeep Singh - Managing Director

Registered Office :

Address : Alkem House,Senapati Bapat Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone : 022 3982 9999

Email : investors@alkem.com / contact@alkem.com

Website : www.alkemlabs.com

Registrar's Details : Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

28Mar USFDA concludes inspection at Alkem La
U.S Food and Drug Administration (USFDA) has concluded inspection at Alk..

28Mar Alkem Laboratories incorporates wholly
Alkem Laboratories has incorporated Wholly Owned Subsidiary (WOS) of the..

06Mar Alkem Laboratories informs about notic
Alkem Laboratories has informed that it attached the Postal Ballot Notic..

28Feb USFDA issues EIR for Alkem Laboratorie
U.S Food and Drug Administration (USFDA) has issued an Establishment Ins..

28Feb Alkem Laboratories informs about press
In furtherance to the intimation captioned ‘US FDA Inspection at Company..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	5042.3	11344.7
Gross Profit	5343.8	13269.9
Operating Profit	6649.2	16432.4
Net Sales	24945.9	90545.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE) 4025.35 (4.81%)	M.Cap ( in Cr) 106860.39
Sanofi India (BSE) 8278.10 (1.76%)	M.Cap ( in Cr) 19064.98
Abbott India (BSE) 25864.85 (0.54%)	M.Cap ( in Cr) 54961.00
Astrazeneca Pharma I (BSE) 5415.40 (2.18%)	M.Cap ( in Cr) 13538.50
Glaxosmithkline Phar (BSE) 2132.75 (3.26%)	M.Cap ( in Cr) 36130.07

Shareholding Pattern

	PROMOTERS	56.74%
	NON-INSTITUTION	18.52%
	MUTUAL FUNDS/UTI	11.92%
	FI/BANKS/INSURANCE	2.75%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name	Hold(%)
Kotak Healthcare Fu...	4.35
DSP Midcap Fund-Reg(G)	4.05
LIC MF Healthcare F...	3.87
Tata India Pharma &...	3.83
Nippon India Nifty ...	3.80
ICICI Pru Nifty Pha...	3.80
Aditya Birla SL Pha...	3.52

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App

Mobile Trading IOS App

Call Us 0755-4350141/142/143, 9425008895

Mutual Funds 0755-4276725, 4276726

Email Uskmlho@kalpatarumulti.com